In this episode, we have the pleasure of hosting Alok Tayi, the co-founder of Vibe Bio.Vibe Bio is a life science company dedicated to investing in biotech firms, with a special focus on rare and overlooked diseases.
In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.
We discuss the complexities of drug development, the advantages of DAOs as an organizational structure and common misconceptions within the Biopharma industry. Alok also shares his insights on the transformative role of AI in drug discovery, discussing its utilization, the methods used for training AI models, the issue of AI bias, and the current limitations and challenges faced in leveraging AI to advance drug development.
Feel free to navigate through any of the topics discussed in the podcast using the timestamps below.
___
⭐ Timestamps:
0:00 Intro
01:51 What led you to create Vibe
02:52 Diseases Vibe Focuses On
04:37 Complexities in Drug Development
7:49 Advantages of DAOs
12:00 Misconceptions in Academia & the Private Sector
16:53 Areas you’re willing to explore with more funding.
23:59 Utilizing AI tools in Drug Discovery
28:50 Bias in AI
32:54 AI Training Methods
36:58 Limits of AI in Drug Discovery
39:56 Implicit Knowledge in Drug Development
49:30 Outro
____
If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below.
If you want to join us on the show as a speaker or have guest ideas, please shoot us an mail at podcast@molecule.to
Special thanks to
Lea: https://twitter.com/lealeata
Alok: https://twitter.com/aloktayi
Learn more about Vibe Bio here: https://vibebio.com/
____
Let's connect:
Website: https://bit.ly/3d6nh2C
X: https://twitter.com/Molecule_dao
Discord: https://discord.com/invite/moleculedao
